Scientists hope the drug, Solanezumab, might be more effective than previously thought. James Gallagher reports.
科学家希望药物solanezumab比以前认为的更加有效。James Gallagher报道。
英语百科
Solanezumab
Solanezumab (proposed INN) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug attracted extensive media coverage proclaiming it as a supposed "breakthrough" although in reality the medical evidence in support of such claims is lacking.